NCT06327217

Brief Summary

A common cause of hip joint pain in the young and active population is femoroacetabular impingement (FAI) syndrome. if FAI is left untreated, the changed morphology will have a negative effect on the existing joint and will contribute to the development of osteoarthritis (OA). Hip arthroscopy is the first choice of operative treatment for FAI. While hip arthroscopy improves the patient reported outcome measures (PROMs), the influence of this treatment on the contribution to the development of osteoarthritis after FAI is to the best of our knowledge still unknown.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
451

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 25, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

March 6, 2024

Last Update Submit

March 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • To evaluate the degree of osteoarthritis 5 to 10 years after a hip arthroscopy in comparison with the non-operative side.

    To evaluate the degree of osteoarthritis, the Kellgren and Lawrence-scale will be used. The scale ranges from 0 to 4: A score of 0 indicates that there is no evidence of osteoarthritis A score of 4 indicates end-stage OA, marked by severe sclerosis, joint space narrowing (sometimes bone-on-bone contact), and large osteophytes.

    5 to 10 years after hip arthroscopy

Secondary Outcomes (5)

  • To evaluate the change in degree of osteoarthritis at 5 to 10 years after a hip arthroscopy in comparison with preoperative/perioperative.

    5 to 10 years after hip arthroscopy

  • To report incidence of total hip replacement within 5 to 10 years after a hip arthroscopy.

    5 to 10 years after hip arthroscopy

  • To determine the functional outcome of patients and, to determine what factors contribute to a good functional outcome 5/10 years after hip arthroscopy.

    5 to 10 years after hip arthroscopy

  • To determine the inter-rater and intra-rater agreement of the Kellgren and Lawrence OA score.

    5 to 10 years after hip arthroscopy

  • To determine patient satisfaction 5-10 years after hip arthroscopy.

    5 to 10 years after hip arthroscopy

Study Arms (1)

Hip arthroscopy 5-10jr

Radiation: Bilateral hip x-rayOther: Questionnaires

Interventions

Patients will be asked to visit the clinic for a bilateral hip x-ray, in order to evaluate the degree os osteoarthritis.

Hip arthroscopy 5-10jr

Patients will be asked to complete questionnaires on function, quality of life and pain (the modified Harris Hip Score (mHHS), Hip Outcome Score (HOS), the World Health Organisation Quality of Life Questionnaire (WHOWOL) and Visual Analogue Scale (VAS) for pain). One question will be asked: 'How satisfied are you with the results of the surgery?' on a 10-point scale.

Hip arthroscopy 5-10jr

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients from a previous hip arthroscopy cohort study, who are between 5 and 10 years of follow-up.

You may qualify if:

  • Patient who participated in the cohort study;
  • At least 5 years of follow up;
  • Patient is able to understand the meaning of the study and is willing to sign the Informed Consent Form.
  • A potential subject who meets any of the following criteria will be excluded from participation in this study:

You may not qualify if:

  • Patient who has had hip arthroscopy of both sides;
  • Patient is unable or unwilling to sing informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reinier Haga Orthopedic Center

Zoetermeer, 2725 NA, Netherlands

Location

MeSH Terms

Conditions

Femoracetabular Impingement

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2024

First Posted

March 25, 2024

Study Start

April 1, 2024

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

March 25, 2024

Record last verified: 2024-03

Locations